Xiangjun Xie

579 citations
17 papers · 407 indexed · h-index 10
Topics
Esophageal Cancer Research and Treatment (3 papers)RNA modifications and cancer (3 papers)Colorectal Cancer Screening and Detection (2 papers)
Partner nations
ChinaAustralia

In The Last Decade

Xiangjun Xie

15 papers receiving 398 citations

Peers

Xiangjun Xie
Comparison fields: 5 of 65
  • Surgery 164
  • Molecular Biology 130
  • Genetics 124
  • Epidemiology 117
  • Oncology 111
Replace Ryan O'Neal with:
Ryan O'Neal United States
Juan Ramón Delgado Spain
Bangbo Zhao China
Wolfgang Stiglbauer Austria
S. Zúñiga Spain
Takahiro Toyokawa Japan
Peng-Tao Guo China
De Sen Wan China
Annalisa Roberti Spain
C.‐J. Hsieh Germany
Xiangjun Xie relative to Ryan O'Neal United States Ryan O'Neal's profile →
Citations per field
00.5×6.9×
Ryan O'Neal · 1×
Citations per year

Countries citing papers authored by Xiangjun Xie

Since Specialization
Citations

This map shows the geographic impact of Xiangjun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjun Xie more than expected).

Fields of papers citing papers by Xiangjun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjun Xie. The network helps show where Xiangjun Xie may publish in the future.

Co-authorship network of co-authors of Xiangjun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjun Xie. A scholar is included among the top collaborators of Xiangjun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjun Xie. Xiangjun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 21
6 14
7
miR-129-3p inhibits NHEJ pathway by targeting SAE1 and represses gastric cancer progression.
21
8 17
9 8
10 5
11 11
12 69
13 40
14 1
15 16
16 124
17 55

About Xiangjun Xie

Xiangjun Xie is a scholar working on Cancer Research, Gastroenterology and Clinical Biochemistry, having authored 17 papers that have together received 407 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (3 papers), RNA modifications and cancer (3 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Gastroenterology (40 citations), Genetics (124 citations) and Oncology (111 citations). Xiangjun Xie has collaborated with scholars based in China and Australia. Frequent co-authors include Yanqing Li, Changqing Li, Xiuli Zuo, Hua Chen, Weiqing Huang, Tao Yu, Chengjun Zhou, Xiaomeng Gu, Xian Jiang and Xueying Sun. Their work appears in journals such as Fuel, The American Journal of Gastroenterology and Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026